glp 1 agonist guidelines How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Glucagon-Like Peptide-1 Receptor Agonists in

For example, certain medications are supplied as dry powders or concentrated solutions that must be combined with a specific volume of sterile water to prepare an injectable solution of the proper concentration

However, safety depends on several factors: The specific peptide and dose The dogs age, breed, and health status The quality and purity of the peptide product The duration of use Some dogs may experience mild injection site irritation or digestive upset

From that concentration, you can calculate the draw volume per dose

The vote was close: eight members voted in favor, six against, and one abstained

doi: 10.1056/NEJMoa0908056

Continue escalating tirzepatide as needed per standard protocols